Cui Rongqi, Zhang Jing
China Medical University, Shenyang, Liaoning, China.
Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Front Immunol. 2025 Jul 18;16:1604271. doi: 10.3389/fimmu.2025.1604271. eCollection 2025.
Suppressor of cytokine signaling (SOCS) is a family of regulatory factors whose expression can be induced by various cytokines, growth factors, and hormones. Autoimmune diseases, chronic inflammatory conditions caused by abnormal immune responses, involve overactive T-cells and B-cells, excessive autoantibody production, and damage to multiple organs and systems. The pathogenic mechanisms of autoimmune diseases are complex, and SOCS proteins, particularly SOCS1, SOCS2, SOCS3, and SOCS5, regulate cytokine receptor signaling through distinct mechanisms, thereby participating in the development and progression of autoimmune diseases. This positions SOCS proteins as potential therapeutic targets for modulating dysregulated immune responses in autoimmune diseases.
细胞因子信号转导抑制因子(SOCS)是一类调节因子家族,其表达可由多种细胞因子、生长因子和激素诱导。自身免疫性疾病是由异常免疫反应引起的慢性炎症性疾病,涉及T细胞和B细胞过度活跃、自身抗体产生过多以及多器官和系统受损。自身免疫性疾病的致病机制复杂,而SOCS蛋白,特别是SOCS1、SOCS2、SOCS3和SOCS5,通过不同机制调节细胞因子受体信号转导,从而参与自身免疫性疾病的发生和发展。这使SOCS蛋白成为调节自身免疫性疾病中失调免疫反应的潜在治疗靶点。